PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3559

  1. 353 Posts.
    lightbulb Created with Sketch. 399
    Jinx, maybe. But I doubt they look to HC to get ideas on optimal CR timing haha

    No doubt there will be more in the future, but give the milestones ahead of us, I am doubtful they will be at this low price
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.